SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-049629
Filing Date
2022-04-25
Accepted
2022-04-25 16:09:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2212652d2_defa14a.htm DEFA14A 10069
2 GRAPHIC tm2212652d2_defa14aimg001.jpg GRAPHIC 132227
3 GRAPHIC tm2212652d2_defa14aimg002.jpg GRAPHIC 80199
  Complete submission text file 0001104659-22-049629.txt   303912
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40536 | Film No.: 22849783
SIC: 2834 Pharmaceutical Preparations